We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Database Analysis Helps Identify “Sweet Spot” for Safe Surgery after Heart Attack

By HospiMedica International staff writers
Posted on 06 Nov 2024

The 2014 perioperative guidelines from the American College of Cardiology and the American Heart Association recommend waiting 60 days after a heart attack before proceeding with elective noncardiac surgery. More...

This recommendation was derived from a study involving 500,000 patients between 1999 and 2004. Most deaths or significant complications that occur post-surgery happen within the first 30 days of recovery, prompting perioperative teams to work diligently to mitigate these risks. Aging patients frequently present with multiple acute or chronic conditions, which challenges physicians to balance the risks associated with surgical care against the patients' expectations for quality of life. A new study now suggests that postponing elective procedures by three to six months after a heart attack may lower the risk of complications for older adults. This research, published in JAMA Surgery, offers critical insights that could lead to updates in decision-making guidelines that have relied on data from two decades ago.

Conducted by researchers at the University of Rochester (Rochester, NY, USA), the study revealed that older adults face double or triple the risk of life-threatening complications—such as debilitating strokes or subsequent heart attacks—if they undergo elective noncardiac surgeries too soon after experiencing a heart attack. A comprehensive analysis of the Medicare database, which includes 5.2 million surgeries from 2017 to 2020 involving patients aged 67 and older, indicates that delaying surgery for three to six months after the most common type of heart attack, known as a non-ST-segment elevation myocardial infarction (NSTEMI), could be beneficial. The researchers aim to identify the “sweet spot” for safely scheduling additional surgical procedures in this high-risk group.

“The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information,” said Laurent Glance, MD, lead author and professor of Anesthesiology and Perioperative Medicine and Public Health Sciences at the University of Rochester Medical Center.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.